glp-1 candidates Comparing Ozempic, Wegovy and Other Drugs Frontiers | GLP-1 Receptor Agonists:

& Vanittanakom, N

Lancet Lond Engl 394:121130 Frias JP, Nauck MA, Van J, Benson C, Bray R, Cui X, Milicevic Z, Urva S, Haupt A, Robins DA (2020) Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens

Accessed 11 Sept 2020

American Academy of Dermatology, Inc

Advertisement Article continues below this ad What started as a drug to help patients with diabetes control their blood sugar in 2022 became a buzzy weight loss treatment among celebrities, who could afford to pay top dollar to use the drugs for an unapproved use

et al.) 391415 (Springer, 2023)